You just read:

ImmunoCellular Therapeutics Treats First Patient in ICT-107 Phase 3 Registrational Trial in Newly Diagnosed Glioblastoma

News provided by

ImmunoCellular Therapeutics, Ltd.

Jun 07, 2016, 06:00 ET